HB

Hans van Bruggen

Hans van Bruggen is an accomplished Chief Scientific Officer at Celegence since July 2022, with extensive expertise in regulatory affairs and operations gained through various roles across multiple companies. Since 2012, Hans has contributed as a service provider and consultant for B. Braun Group, focusing on the implementation of processes for XEVMPD and IDMP data management. With experience dating back to 2001 in organizations such as the Drug Information Association, Hans has presented and co-organized numerous regulatory affairs workshops and courses. In addition to a background in publishing regulatory submissions for companies like Astellas Pharma and Leadiant Biosciences Ltd, Hans has served on the board of the IRISS Forum, advocating for improved regulatory information exchange. Academic qualifications include an MSc in Pharmaceutical Medicine from the University of Surrey and a degree in Physiology Pharmacology from OLAN.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


TOPRA - The Organisation for Professionals in Regulatory Affairs

1 followers

TOPRA, The Organisation for Professionals in Regulatory Affairs, is a non-profit, non-political organisation which seeks to advance the status of the regulatory profession through education and provision of information to its members. Our current membership is drawn from over 50 countries, and members worldwide are actively involved in delivering the services needed by busy regulatory specialists. Members are drawn from industry, regulatory agencies and the consultancy community, and work in all sectors including medical technologies, biotech, borderline products and pharmaceuticals.


Employees

11-50

Links